Table 1 Clinical and pathologic characteristics of patients by treatment group
3D-CRT without brachytherapy (n = 55) | 3D-CRT with brachytherapy (n = 58) | P value | |
|---|---|---|---|
Age (years, median) | 49 (26–73) | 50 (27–76) | 0.313 |
FIGO stage | 0.947 | ||
IB1 | 11 (20.0 %) | 9 (15.5 %) | |
IB2 | 13 (24.6 %) | 15 (25.9 %) | |
IIA1 | 19 (34.5 %) | 24 (41.4 % | |
IIA2 | 12 (21.8 %) | 10 (17.2 %) | |
Histology | 0.785 | ||
Squamous cell carcinoma | 47 (85.5 %) | 51 (87.9 %) | |
Adenocarcinoma | 8 (14.5 %) | 7 (12.1 %) | |
Grade | 0.719 | ||
1 | 8 (14.5 %) | 9 (15.5 %) | |
2 | 30 (54.4 %) | 33 (56.9 %) | |
3 | 17 (30.9 %) | 16 (27.6 %) | |
Number of retrieved lymph nodes | 24.9 ± 4.2 | 24.7 ± 3.7 | 0.825 |
Number of positive lymph nodes | 1 | ||
≤3 | 51 (92.7 %) | 53 (96.4 %) | |
>3 | 4 (7.3 %) | 5 (3.6 %) |